Synthetic nanofiber tissue for the veterinary market
Nanofiber Veterinary offers a patent-pending treatment for osteoarthritis leveraging recent advances in biosynthetic tissue engineering, using veterinary as an effective means to innovate for the human market. Osteoarthritis impacts over 27 million people in just the USA, and over 100MM people worldwide each year, with NO CURE. It is a $15 billion a year global market for just this one form of arthritis. Patients must endure the pain through drugs and rehabilitation or resort to horrendous surgical joint replacements. Nanofiber Veterinary offers a simple and effective means to regenerate joints via its proprietary injections of patent-pending advanced technologies.